A specific transduction mechanism for the glutamate action on phosphoinositide metabolism via the quisqualate metabotropic receptor in rat brain synaptoneurosomes: II. Calcium dependency, cadmium inhibition

J Neurochem. 1991 Nov;57(5):1501-9. doi: 10.1111/j.1471-4159.1991.tb06344.x.

Abstract

In this article, we demonstrate that an increase in intracellular Ca2+ concentration may represent a specific common step(s) in the mechanism(s) of action of glutamate (Glu) and depolarizing agents on formation of inositol phosphates (IPs) in 8-day-old rat forebrain synaptoneurosomes. In fact, A23187, a Ca2+ ionophore, induces a dose-dependent accumulation of IPs, which is not additive with that evoked by Glu and K+ but is slightly synergistic with that induced by carbachol. In addition, Glu and K+ augment the intracellular Ca2+ concentration in synaptoneurosome preparations as measured by the fura-2 assay. The absence of external Ca2+ decreases basal and Glu-, and K(+)-stimulated formation of IPs. Cd2+ (100 microM) fully inhibits both Glu- and K(+)-evoked formation of IPs without affecting the carbachol-elicited response of IPs. Zn2+ inhibits Glu- and K(+)-stimulated accumulation of IPs (IC50 approximately 0.4 mM) but with a lower affinity than Cd2+ (IC50 approximately 0.035 mM). The organic Ca2+ channel blockers verapamil (10 microM), nifedipine (10 microM), omega-conotoxin (2 microM), and amiloride (10 microM) as well as the inorganic blockers Co2+ (100 microM) and La3+ (100 microM) block neither Glu- nor K(+)-evoked formation of IPs, a result suggesting that the opening of the L-, T-, N-, or P-type Ca2+ channels does not participate in these responses. All these data suggest that an increase in intracellular Ca2+ concentration resulting from an influx of Ca2+, sensitive to Cd2+ but not to other classical Ca2+ antagonists, may play a key role in the transduction mechanism activated by Glu or depolarizing agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cadmium / pharmacology*
  • Calcimycin / pharmacology
  • Calcium / pharmacology*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Carbachol / pharmacology
  • Cations, Divalent
  • Glutamates / pharmacology*
  • Glutamic Acid
  • Inositol Phosphates / metabolism*
  • Membrane Potentials / drug effects
  • Phosphatidylinositols / metabolism*
  • Potassium / pharmacology
  • Prosencephalon / metabolism*
  • Quisqualic Acid / metabolism
  • Rats
  • Receptors, AMPA
  • Receptors, Neurotransmitter / drug effects
  • Receptors, Neurotransmitter / physiology*
  • Signal Transduction* / drug effects
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism*
  • Synaptosomes / physiology

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Cations, Divalent
  • Glutamates
  • Inositol Phosphates
  • Phosphatidylinositols
  • Receptors, AMPA
  • Receptors, Neurotransmitter
  • Cadmium
  • Calcimycin
  • Glutamic Acid
  • Quisqualic Acid
  • Carbachol
  • Potassium
  • Calcium